Viewing Study NCT03221933


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-03-05 @ 11:31 AM
Study NCT ID: NCT03221933
Status: COMPLETED
Last Update Posted: 2017-12-12
First Post: 2017-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Recombinant Human Growth Hormone Injection(JINTOPIN AQ)for Short Children With Small for SGA
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module